Journal rankings · indicator year 2024
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2024
Psychiatry and Mental health journal rankings 2024
144 ranked journals · Subfield in Medicine
Psychiatry and Mental health has 144 ranked journals in 2024. The median OJR fell 0.08 on 2023 to 0.83, below the world average of 1.00; Q1 starts at OJR 1.17. The top three are Alzheimer s & Dementia, Alzheimer s Research & Therapy, and The Lancet Healthy Longevity.
Ranks and citation indicators: 2024. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2021–2023, the window the 2024 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery980
- Pulmonary and Respiratory Medicine364
- Public Health, Environmental and Occupational Health316
- Cardiology and Cardiovascular Medicine289
- Infectious Diseases263
- Oncology243
- Epidemiology187
- Neurology175
- Radiology, Nuclear Medicine and Imaging161
- Physiology159
- Endocrinology, Diabetes and Metabolism157
- Psychiatry and Mental health144
Show all 42 subfields
- Orthopedics and Sports Medicine125
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology92
- Obstetrics and Gynecology85
- Hematology83
- Rheumatology67
- Nephrology65
- Complementary and alternative medicine59
- Reproductive Medicine52
- Pharmacology49
- Emergency Medicine42
- Geriatrics and Gerontology37
- Rehabilitation34
- Otorhinolaryngology33
- Hepatology30
- Pathology and Forensic Medicine29
- Immunology and Allergy26
- Critical Care and Intensive Care Medicine23
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology12
- Health Informatics9
- Gastroenterology7
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
144 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2023. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2021–2023, the window the 2024 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2021–2023 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2015 to 2024. | Compare |
|---|---|---|---|---|---|---|---|
1Alzheimer s & DementiaWiley · United States | 3.79Q1 | 9.97 1.86 down from 2023 | 1,108 | 100% | $4,200 | ||
2Alzheimer s Research & TherapyOABioMed Central · United Kingdom | 3.11Q1 | 8.68 0.32 down from 2023 | 596 | 100% | $4,290 | ||
3The Lancet Healthy LongevityOAElsevier BV · United Kingdom | 3.10Q1 | 8.00 0.01 down from 2023 | 399 | 100% | $6,680 | ||
4The Journal of Prevention of Alzheimer s DiseaseOASpringer Science+Business Media · Switzerland | 2.80Q1 | 7.37 0.63 up from 2023 | 310 | 100% | $4,060 | ||
5JMIR AgingOACanada | 2.69Q1 | 5.15 0.91 down from 2023 | 220 | 100% | $1,605 | ||
6The Journal of Headache and PainOASpringer Nature · Italy | 2.50Q1 | 8.85 0.65 up from 2023 | 461 | 100% | $3,990 | ||
7CNS DrugsAdis, Springer Healthcare · New Zealand | 2.48Q1 | 8.72 0.24 up from 2023 | 248 | 68% | $5,090 | ||
8Digital BiomarkersOAKarger Publishers · Switzerland | 2.39Q1 | 4.25 2.46 down from 2023 | 48 | 100% | $990 | ||
9Alzheimer s & Dementia Translational Research & Clinical InterventionsOAElsevier BV · United States | 2.27Q1 | 6.89 0.99 up from 2023 | 295 | 100% | $2,540 | ||
10General PsychiatryOABMJ · United Kingdom | 2.22Q1 | 6.60 0.62 up from 2023 | 183 | 100% | — | ||
11EpilepsiaWiley · Denmark | 2.20Q1 | 6.72 0.13 down from 2023 | 962 | 81% | $4,360 | ||
12Alzheimer s & Dementia Diagnosis Assessment & Disease MonitoringOAElsevier BV · United States | 1.88Q1 | 4.97 0.50 up from 2023 | 349 | 100% | $2,540 | ||
13Annals of General PsychiatryOABioMed Central · United Kingdom | 1.76Q1 | 3.67 1.47 down from 2023 | 161 | 100% | $3,090 | ||
14CephalalgiaSAGE Publishing · United Kingdom | 1.73Q1 | 5.12 0.44 down from 2023 | 374 | 99% | $3,000 | ||
15Neurology and TherapyOAAdis, Springer Healthcare · United Kingdom | 1.68Q1 | 5.10 0.59 up from 2023 | 316 | 100% | $7,400 | ||
16SchizophreniaOANature Portfolio · United Kingdom | 1.67Q1 | —no 2023 value | 61 | — | $3,590 | ||
17Neurologic ClinicsElsevier BV · United States | 1.64Q1 | 3.68 0.76 up from 2023 | 170 | 9% | $3,650 | ||
18Therapeutic Advances in PsychopharmacologyOASAGE Publishing · United Kingdom | 1.61Q1 | 5.03 1.00 up from 2023 | 126 | 100% | $2,650 | ||
19Current Pain and Headache ReportsSpringer Science+Business Media · United States | 1.60Q1 | 4.30 0.20 down from 2023 | 279 | 34% | $4,590 | ||
20Acta Psychiatrica ScandinavicaWiley · United Kingdom | 1.59Q1 | 4.69 0.39 down from 2023 | 336 | 78% | $4,880 | ||
21Schizophrenia BulletinOxford University Press · United Kingdom | 1.59Q1 | 4.76 0.05 down from 2023 | 468 | 97% | $4,981 | ||
22The Journal of Clinical PsychiatryPhysicians Postgraduate Press, Inc. · United States | 1.57Q1 | 3.79 0.43 up from 2023 | 514 | 45% | — | ||
23SchizophreniaOASpringer Science+Business Media | 1.54Q1 | 4.65 0.93 up from 2023 | 202 | 100% | $3,890 | ||
24DementiaSAGE Publishing · United Kingdom | 1.39Q1 | 2.85 0.24 down from 2023 | 313 | 76% | $3,650 | ||
25European Archives of Psychiatry and Clinical NeuroscienceSpringer Science+Business Media · Germany | 1.38Q1 | 4.03 0.04 down from 2023 | 483 | 55% | $2,990 | ||
26Aging & Mental HealthRoutledge · United Kingdom | 1.34Q1 | 2.78 0.46 down from 2023 | 618 | 56% | — | ||
27International Journal of Bipolar DisordersOASpringer Science+Business Media · Germany | 1.27Q1 | 3.89 0.28 up from 2023 | 112 | 100% | $2,990 | ||
28Expert Review of NeurotherapeuticsTaylor & Francis · United Kingdom | 1.27Q1 | 3.90 0.11 down from 2023 | 279 | 35% | — | ||
29Psychiatry and Clinical NeurosciencesWiley · Australia | 1.25Q1 | 4.15 1.39 up from 2023 | 309 | 82% | $3,240 | ||
30The International Journal of NeuropsychopharmacologyOAUniversity of Oxford · United Kingdom | 1.25Q1 | 4.21 0.07 down from 2023 | 233 | 100% | $2,693 | ||
31International Journal of Geriatric PsychiatryWiley · United Kingdom | 1.24Q1 | 3.00 0.71 down from 2023 | 503 | 71% | $4,600 | ||
32NeuropsychologyAmerican Psychological Association · United States | 1.23Q1 | 3.18 0.36 up from 2023 | 225 | 47% | — | ||
33Headache The Journal of Head and Face PainWiley · United States | 1.22Q1 | 3.61 0.81 down from 2023 | 506 | 65% | $4,150 | ||
34Journal of Psychosomatic ResearchElsevier BV · United States | 1.21Q1 | 3.48 0.14 down from 2023 | 691 | 45% | $3,760 | ||
35International Journal of Sexual HealthRoutledge · United States | 1.21Q1 | 2.21 1.11 down from 2023 | 140 | 98% | — | ||
36Journal of Sex & Marital TherapyRoutledge · United States | 1.17Q1 | 2.65 0.25 up from 2023 | 205 | 36% | — | ||
37Schizophrenia Research CognitionOAElsevier BV · United States | 1.16Q2 | 3.49 0.49 up from 2023 | 101 | 100% | $3,130 | ||
38Journal of Alzheimer s Disease ReportsOAIOS Press · Netherlands | 1.16Q2 | 3.29 0.15 up from 2023 | 241 | 100% | — | ||
39Journal of Alzheimer s DiseaseIOS Press · Netherlands | 1.14Q2 | 3.21 0.42 down from 2023 | 2,431 | 46% | — | ||
40Brain and BehaviorOAWiley · United States | 1.13Q2 | 3.19 0.03 down from 2023 | 1,285 | 100% | $3,630 | ||
41The Journal of Sexual MedicineElsevier BV · United Kingdom | 1.13Q2 | 2.71 0.51 down from 2023 | 568 | 66% | $3,550 | ||
42American Journal of Alzheimer s Disease & Other Dementias®OASAGE Publishing · United Kingdom | 1.12Q2 | 3.29 0.20 up from 2023 | 98 | 100% | $2,650 | ||
43Sexual Medicine ReviewsElsevier BV · United States | 1.12Q2 | 3.08 1.20 down from 2023 | 143 | 28% | $3,550 | ||
44Epilepsia OpenOAWiley · United States | 1.11Q2 | 2.99 0.04 down from 2023 | 382 | 100% | $3,120 | ||
45American Journal of Geriatric PsychiatryElsevier BV · United States | 1.10Q2 | 2.25 0.16 down from 2023 | 501 | 19% | $4,400 | ||
46Journal of Psychiatry and NeuroscienceOACanadian Medical Association · Canada | 1.08Q2 | 2.90 0.84 down from 2023 | 169 | 100% | — | ||
47Developmental Medicine & Child NeurologyWiley · United Kingdom | 1.07Q2 | 2.98 0.17 up from 2023 | 867 | 84% | $5,300 | ||
48Neuropsychiatric Disease and TreatmentOADove Medical Press · New Zealand | 1.07Q2 | 3.31 0.20 up from 2023 | 843 | 100% | $2,836 | ||
49Clinical GerontologistTaylor & Francis · United States | 1.06Q2 | 2.53 0.45 down from 2023 | 252 | 52% | — | ||
50Pediatric NeurologyElsevier BV · United States | 1.06Q2 | 2.17 0.69 down from 2023 | 592 | 29% | $3,520 |
Subfields of Medicine, with Psychiatry and Mental health highlighted.
- Surgery980
- Pulmonary and Respiratory Medicine364
- Public Health, Environmental and Occupational Health316
- Cardiology and Cardiovascular Medicine289
- Infectious Diseases263
- Oncology243
- Epidemiology187
- Neurology175
- Radiology, Nuclear Medicine and Imaging161
- Physiology159
- Endocrinology, Diabetes and Metabolism157
- Psychiatry and Mental health144
- Orthopedics and Sports Medicine125
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology92
- Obstetrics and Gynecology85
- Hematology83
- Rheumatology67
- Nephrology65
- Complementary and alternative medicine59
- Reproductive Medicine52
- Pharmacology49
- Emergency Medicine42
- Geriatrics and Gerontology37
- Rehabilitation34
- Otorhinolaryngology33
- Hepatology30
- Pathology and Forensic Medicine29
- Immunology and Allergy26
- Critical Care and Intensive Care Medicine23
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology12
- Health Informatics9
- Gastroenterology7
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2024. Corpus-wide, 87.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
14 additional Psychiatry and Mental health journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2021–2023, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2024. Publication window: 2021–2023. How these summaries are calculated
- Ranked journals
- 144
- Window papers (baseline)
- 78,465 +8.8% from indicator year 2021
- Median OJR
- 0.8335 -8.1% from indicator year 2021
- Rising journals (2025)
- 7
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2021–2023 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 65 | 71 | 74 | 82 | 82 | 87 | 89 | 93 | 98 | 100 | 102 | 107 | 109 | 119 | 119 | 123 | 134 | 142 | 141 | 142 | 140 | 145 | 147 | 144 | 144 | 139 | |
| Window papers (baseline) | 20,748 | 23,511 | 25,742 | 27,920 | 29,159 | 31,333 | 33,934 | 37,512 | 41,192 | 44,742 | 46,739 | 49,131 | 50,177 | 52,432 | 55,064 | 58,021 | 60,510 | 61,715 | 63,841 | 65,471 | 68,365 | 72,111 | 76,708 | 78,267 | 78,465 | 79,078 | |
| Median OJR | 0.82 | 0.772 | 0.79 | 0.767 | 0.87 | 0.8329 | 0.89 | 0.929 | 0.92 | 0.996 | 0.95 | 1.03 | 1.013 | 0.964 | 1.0034 | 1.009 | 0.982 | 0.959 | 0.976 | 0.985 | 1.0031 | 0.907 | 0.928 | 0.911 | 0.8335 | 0.88 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.